DHG leads September cash dividend wave; 50% payout, VND 654B
This Aveluro analysis covers DHG on HOSE in the Health Care sector. The classified event type is dividend announcement, with positive sentiment and a deterministic market-impact score of 4.0/10. Aveluro classifies this story as a positive catalyst in the stock's news coverage. Source coverage came from CafeF - Doanh nghiệp, classified as a primary/top-tier source.
Key Facts
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Overview
Several Vietnamese listed companies, including Dược Hậu Giang (DHG), Pharmedic (PMC), Dược phẩm Trung ương CPC1 (DP1), Rạng Đông (RAL), Giống cây trồng Việt Nam (NSC), Phân bón và Hóa chất Dầu khí Miền Bắc (PMB), May Nam Định (NJC), and Phân bón và Hóa chất Dầu khí Miền Trung (PCE), are set to pay cash dividends in September 2025. DHG leads with a 50% cash dividend, while others range from 10% to 25%.
Key Facts
- DHG will pay VND 5,000 per share (50% cash dividend) on Sept 30, 2025; ex-date Sept 14, record date Sept 15.
- DHG’s total payout is nearly VND 654 billion, based on ~130.75 million shares outstanding.
- DHG’s 2025 total cash dividend reaches 100% (VND 10,000/share), including a prior payment in May.
- Taisho Pharmaceutical (51% stake) will receive ~VND 333.5 billion; SCIC (43.3%) ~VND 283 billion.
- PMC pays 19.6% (VND 1,964/share) on Sept 9, totaling over VND 18 billion.
- DP1 pays 25% (VND 2,500/share); record date Sept 9, payment by Oct 15.
- RAL pays 25% (VND 2,500/share) on Sept 10, costing nearly VND 60 billion.
- NSC pays 20% (VND 2,000/share) on Sept 9, totaling over VND 35 billion; PAN FARM (80% stake) receives ~VND 28 billion.
- PMB pays 10% (VND 1,000/share) on Sept 28; NJC pays 15% (VND 1,500/share) on Oct 8.
- PCE pays 14% (VND 1,400/share); record date not fully disclosed in the article.
What Happened
According to company announcements, DHG will finalize shareholder lists in mid-September and disburse a 50% cash dividend on Sept 30, 2025. This is the final installment of its 2025 dividend plan, bringing the total cash dividend for the year to 100% of par value. The company will pay out nearly VND 654 billion, with the majority going to its two largest shareholders: Taisho Pharmaceutical (51%) and State Capital Investment Corporation (SCIC, 43.3%).
Other companies are following a similar pattern. PMC will pay a third installment of 19.6% on Sept 9, while DP1 will pay 25% with a record date of Sept 9. RAL maintains its high payout tradition with a 25% dividend on Sept 10. In agriculture, NSC will distribute 20% on Sept 9, with its parent PAN FARM receiving a significant share. Fertilizer and chemical firms PMB and PCE, as well as textile company NJC, are also paying dividends in the 10-15% range.
Market Context
DHG, listed on HOSE, closed at VND 95,600 on Aug 30, 2026, reflecting a yield of over 5% for the upcoming 50% dividend alone. The stock has been a consistent dividend payer, and this payout reinforces its appeal to income-focused investors. Other affected tickers, such as PMC (HOSE, VND 116,900), RAL (HOSE, VND 77,700), and DP1 (HNX, VND 31,100), also show strong dividend yields. The September dividend wave comes amid a broader market trend where Vietnamese companies are rewarding shareholders with cash distributions, supported by robust earnings in sectors like pharmaceuticals, consumer staples, and agriculture.
Strategic Significance
For long-term investors, the concentrated dividend payments highlight the cash-generative nature of these businesses, particularly in the pharmaceutical sector. DHG’s 100% cash dividend for 2025 underscores its strong balance sheet and commitment to shareholder returns, even as it navigates competitive pressures. The involvement of strategic shareholders like Taisho Pharmaceutical and SCIC provides stability and governance oversight. For smaller caps like NSC and PMB, consistent dividends may signal financial health and management confidence, which could attract institutional interest. However, investors should assess whether such payouts are sustainable given future capital expenditure needs and market conditions.
What to Watch
- DHG’s Q3 2025 earnings release to see if cash flow supports continued high dividends.
- PMC’s and DP1’s ability to maintain dividend levels amid regulatory changes in the pharmaceutical sector.
- NSC’s agricultural performance and PAN FARM’s consolidation strategy.
- Any changes in foreign ownership limits or dividend tax policies affecting these payouts.
- PMB and PCE’s operational results, given volatility in fertilizer and chemical prices.